Related Experiment Video
Updated: Aug 1, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
CanScreen5, a global repository for breast, cervical and colorectal cancer screening programs
Li Zhang1, Isabel Mosquera1, Eric Lucas1
1International Agency for Research on Cancer, Lyon, France.
Global cancer screening programs show significant variation in organization and performance. The CanScreen5 project highlights the need for improved data quality and resource-stratified approaches, especially in low-resource settings.
Area of Science:
- Public Health
- Epidemiology
- Cancer Research
Background:
- Cancer screening programs are crucial for early detection and improved patient outcomes.
- Global disparities exist in the implementation and effectiveness of cancer screening initiatives.
- The CanScreen5 project addresses the need for standardized data collection and performance evaluation.
Purpose of the Study:
- To establish a global repository of cancer screening data (breast, cervical, colorectal).
- To assess the status and performance of cancer screening programs worldwide using harmonized criteria.
- To identify variations in program organization, coverage, and detection rates.
Main Methods:
- Data collection from national Ministries of Health.
- Quality validation of reported data.
- Publicly accessible web-based portal for data dissemination.
- Harmonized criteria and indicators for performance assessment.
Main Results:
- 84 countries reported data for breast (57), cervical (75), or colorectal (51) cancer screening programs by September 2022.
- Significant heterogeneity observed in program organization and performance metrics.
- Wide variability in screening coverage reported, e.g., breast cancer (1.7%–85.5%), cervical cancer (2.1%–86.3%), colorectal cancer (0.6%–64.5%).
- Inconsistent data for performance indicators across the screening continuum.
Conclusions:
- Substantial differences in cancer screening program organization and performance necessitate targeted improvements.
- Robust information systems and quality assurance are essential for effective cancer screening.
- Resource-limited settings require tailored, resource-stratified screening strategies.
More Related Videos
10:13A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells
Published on: July 3, 2013
09:08Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
Related Concept Videos
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies
There are several types of targeted therapies against...